Our projects

Entrepreneurship at the service of the patient.

The MEARY Center evolve in an ecosystem of research and development and innovation which constitutes a continuum between fundamental research, applied research, technology transfer, clinical research, and industrial R&D.

Clinical trials

SMART101 by SMART IMMUNE

The MEARY Center is in charge of the manufacturing of SMART101, developed by Smart Immune, as part of two Phase I/II clinical trials.

These trials are evaluating the safety and efficacy of SMART101 in accelerating immune reconstitution to fight infection and relapse after allogeneic hematopoietic stem cell transplantation.

Learn more

Clinical trials

SECRET-HF

Treatment of nonischemic dilated cardiomyopathy by intravenous infusions of the extracellular vesicle-enriched secretome of cardiovascular progenitor cells.

Learn more

Tech transfer

RHU EpCART

As of December 2021, 17 projects have been selected for funding under the RHU, including the EpCART project, which has received nearly 10 million euros. Led by Dr. Sebastian Amigorena, one of the Mnemo Therapeutics scientific co-founders and head of the Immune Responses and Cancer team at Institut Curie, the EpCART project aims to obtain clinical validation of a new approach of CAR-T cell immunotherapy.

Learn more